LFWD

SEC filing LFWD Appoints Keith D. Rose, M.D. as Chief Medical Officer

14d ago

News Lifeward expects 2026 revenue similar to 2025 following Oratech acquisition and $10M convertible note financing

18d ago

SEC filing LFWD Reports $3.9M Revenue, $6.70 Loss per Share in Q1 2026

18d ago

SEC filing LFWD Reports $12M Revenue, $2.1M Net Income, +15% YoY, Announces $500K Severance for VP Lynch

39d ago

SEC filing LFWD Acquires Oratech Pharma for $50M in Shares, Adds $10M Convertible Notes, Revenue Sharing Deal

68d ago

SEC filing LFWD Reports 39.7% Shareholder Quorum, Approves Oratech Acquisition, Elects External Directors, Increases Share Pool, Grants CEO Equity, Reappoints Auditor

81d ago

SEC filing LFWD Regains Nasdaq Listing Compliance, $1.00+ Bid Price for 10 Consecutive Days

83d ago

News Billionaire Bill Ackman Buys 2 Brilliant Artificial Intelligence (AI) Stocks -- They Could Soar in the Next Year, According to Wall Street

106d ago

SEC filing LFWD Receives Nasdaq Notification Extending Compliance Period to August 3, 2026; Plans Reverse Share Split Ratio of 1-for-12

113d ago

Scanner Unusual volume (4.6x average)

117d ago

News Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress

124d ago

SEC filing LFWD Announces 8-Member Board, Seeks Approval for Oratech Acquisition, Share Issuance

124d ago